Funds

Sector Healthcare Value Fund Y GBP Acc

IE00BMXR2613:GBP

Sector Healthcare Value Fund Y GBP Acc

Actions
  • Price (GBP)141.87
  • Today's Change0.09 / 0.06%
  • 1 Year change+12.78%
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find Funds and ETFs
Find Funds and ETFs
Use our fund screener to discover other asset types.
 
Funds ScreenerGo to the Funds Screener

Profile and investment

Fund typeOpen Ended Investment Company
Investment style (stocks)Market Cap: Large
Investment Style: Value
Income treatmentAccumulation
Morningstar categorySector Equity Healthcare
IMA sector--
Launch date16 Oct 2020
Price currencyGBP
DomicileIreland
ISINIE00BMXR2613
Manager & start date
Trond Horneland
16 Nov 2010
Pricing frequencyDaily
Fund size
376.71m GBP
As of Oct 31 2024
Share class size
157.84m GBP
As of Oct 31 2024
Ongoing charge1.35%
Initial charge--
Max annual charge0.40%
Exit charge--
Min. initial investment--
Min. additional investment--
Min. regular investment--
UK ISA--
Available for saleDenmark, Finland, Iceland, Ireland, Luxembourg, Norway, Sweden, Switzerland, United Kingdom
More ▼

Top 5 holdings

Top 5 holdings as a per cent of portfolio
--28.14%0.00%28.14%
Category average% Net assets% Short% Long
Company1 year changePortfolio weightLong allocation
GSK plc
GSK:LSE
-2.16%6.45%
Gilead Sciences Inc
GILD:NSQ
+23.55%6.33%
Pfizer Inc
PFE:NYQ
-10.03%5.50%
Roche Holding AG
ROG:SWX
+9.18%5.00%
Bristol-Myers Squibb Co
BMY:NYQ
+15.87%4.88%
Per cent of portfolio in top 5 holdings: 28.14%
Top 10 Holdings

Diversification

Asset type

Asset type

Non-UK stock89.08%
UK stock7.26%
Cash3.65%
UK bond0.00%
Non-UK bond0.00%
Other0.00%

Top 5 sectors

Healthcare95.85%
Basic Materials0.49%

Top 5 regions

United States58.75%
Europe - ex Euro14.06%
Eurozone9.92%
United Kingdom7.26%
Japan6.36%
Sector and region weightings are calculated using only long position holdings of the portfolio.
The performance data shown in tables and graphs on this page is calculated in GBX of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.
The videos and white papers displayed on this page have not been devised by The Financial Times Limited ("FT"). FT has not selected, modified or otherwise exercised control over the content of the videos or white papers prior to their transmission, or their receipt by you. The videos, white papers and other documents displayed on this page are paid promotional materials provided by the fund company. Any prospectus you view on this page has not been approved by FT and FT is not responsible for the content of the prospectus.
The information made available to you does not constitute the giving of investment advice or an offer to sell or the solicitation of an offer to buy any security of any enterprise in any jurisdiction. The securities listed above are not registered and will not be registered for sale in the United Sates and cannot be purchased by U.S. investors as the securities can only be purchased in jurisdictions where they have been registered for sale or where an exemption from registration applies. The offer, sale or delivery of the securities within the United States or to, or for the account or benefit of, U.S. Persons is not permitted except pursuant to an exemption from registration under U.S. securities laws, which may not be available; and the availability of the information through the website does not alter or change the persons eligible to purchase the security.
All managed funds data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2024
All Rights reserved
© 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.